Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Longley

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Hematology/Oncology Clinics of North America|July 26, 2000
New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitorsB J Longley, Y Ma, E Carter, et al.
Journal of the American Academy of Dermatology|December 1, 1992
Acral persistent papular mucinosisS W Fosko, M I Perez, B J Longley
Journal of Virology|April 1, 1995
Papilloma formation in human foreskin xenografts after inoculation of human papillomavirus type 16 DNAJ L Brandsma, D G Brownstein, W Xiao, et al.
Cutis|November 2, 1999
Eruptive paraneoplastic keloidsL M Coppa, M Alam, B J Longley, et al.
Cutis|April 28, 2001
Kwashiorkor in patients with AIDSM Alam, M E Grossman, B J Longley, et al.
International Journal of Dermatology|April 1, 1996
Multiple tumors of the follicular infundibulumS A Kolenik, J L Bolognia, F M Castiglione, et al.
Cutis|July 6, 2000
Fusarium fingernail infection responsive to fluconazole intermittent therapyS S Tseng, B J Longley, R K Scher, et al.
The Journal of Investigative Dermatology|January 29, 2000
Indolinone derivatives inhibit constitutively activated KIT mutants and kill neoplastic mast cellsY Ma, E Carter, X Wang, et al.
Leprosy Review|December 1, 1986
Lepromin stimulates interleukin-2 production and interleukin-2 receptor expression in situ in lepromatous leprosy patientsB J Longley, A Haregewoin, W de Beaumount, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 22, 2001
SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unitN V Botchkareva, M Khlgatian, B J Longley, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Hematology/Oncology Clinics of North America|July 26, 2000
New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitorsB J Longley, Y Ma, E Carter, et al.
Journal of the American Academy of Dermatology|December 1, 1992
Acral persistent papular mucinosisS W Fosko, M I Perez, B J Longley
Journal of Virology|April 1, 1995
Papilloma formation in human foreskin xenografts after inoculation of human papillomavirus type 16 DNAJ L Brandsma, D G Brownstein, W Xiao, et al.
Cutis|November 2, 1999
Eruptive paraneoplastic keloidsL M Coppa, M Alam, B J Longley, et al.
Cutis|April 28, 2001
Kwashiorkor in patients with AIDSM Alam, M E Grossman, B J Longley, et al.
International Journal of Dermatology|April 1, 1996
Multiple tumors of the follicular infundibulumS A Kolenik, J L Bolognia, F M Castiglione, et al.
Cutis|July 6, 2000
Fusarium fingernail infection responsive to fluconazole intermittent therapyS S Tseng, B J Longley, R K Scher, et al.
The Journal of Investigative Dermatology|January 29, 2000
Indolinone derivatives inhibit constitutively activated KIT mutants and kill neoplastic mast cellsY Ma, E Carter, X Wang, et al.
Leprosy Review|December 1, 1986
Lepromin stimulates interleukin-2 production and interleukin-2 receptor expression in situ in lepromatous leprosy patientsB J Longley, A Haregewoin, W de Beaumount, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 22, 2001
SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unitN V Botchkareva, M Khlgatian, B J Longley, et al.
Pageof 4